BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35133686)

  • 1. Alcohol dehydrogenase expression patterns in normal prostate, benign prostatic hyperplasia, and prostatic adenocarcinoma in African American and Caucasian men.
    Stamis SA; Heath EI; Lucas S; Boerner J; Slusher LB
    Prostate; 2022 May; 82(6):666-675. PubMed ID: 35133686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
    Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
    Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulated gelsolin expression in hyperplastic and neoplastic lesions of the prostate.
    Lee HK; Driscoll D; Asch H; Asch B; Zhang PJ
    Prostate; 1999 Jun; 40(1):14-9. PubMed ID: 10344719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways.
    White JA; Kaninjing ET; Adeniji KA; Jibrin P; Obafunwa JO; Ogo CN; Mohammed F; Popoola A; Fatiregun OA; Oluwole OP; Thorpe RJ; Karanam B; Elhussin I; Ambs S; Tang W; Davis M; Polak P; Campbell MJ; Brignole KR; Rotimi SO; Dean-Colomb W; Odedina FT; Yates C
    Prostate; 2024 Apr; 84(5):460-472. PubMed ID: 38192023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence.
    Pettaway CA; Lamerato LE; Eaddy MT; Edwards JK; Hogue SL; Crane MM
    BJU Int; 2011 Oct; 108(8):1302-8. PubMed ID: 21371244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression pattern, ethanol-metabolizing activities, and cellular localization of alcohol and aldehyde dehydrogenases in human pancreas: implications for pathogenesis of alcohol-induced pancreatic injury.
    Chiang CP; Wu CW; Lee SP; Chung CC; Wang CW; Lee SL; Nieh S; Yin SJ
    Alcohol Clin Exp Res; 2009 Jun; 33(6):1059-68. PubMed ID: 19382905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
    Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
    Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
    Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue.
    Lin VK; Wang D; Lee IL; Vasquez D; Fagelson JE; McConnell JD
    Prostate; 2000 Aug; 44(3):193-203. PubMed ID: 10906735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative real-time RT-PCR of CD24 mRNA in the detection of prostate cancer.
    Schostak M; Krause H; Miller K; Schrader M; Weikert S; Christoph F; Kempkensteffen C; Kollermann J
    BMC Urol; 2006 Mar; 6():7. PubMed ID: 16539730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of estrogen receptor-B ( ER-B ) in bengin and malignant prostatic epithelial cells and its correlation with the clinico-pathological features.
    Gabal SM; Habib FM; Helmy DO; Ibrahim MF
    J Egypt Natl Canc Inst; 2007 Dec; 19(4):239-48. PubMed ID: 19672287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?
    Shah R; Mucci NR; Amin A; Macoska JA; Rubin MA
    Am J Pathol; 2001 May; 158(5):1767-73. PubMed ID: 11337374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression pattern, ethanol-metabolizing activities, and cellular localization of alcohol and aldehyde dehydrogenases in human large bowel: association of the functional polymorphisms of ADH and ALDH genes with hemorrhoids and colorectal cancer.
    Chiang CP; Jao SW; Lee SP; Chen PC; Chung CC; Lee SL; Nieh S; Yin SJ
    Alcohol; 2012 Feb; 46(1):37-49. PubMed ID: 21940137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Pookot D; Li LC; Tabatabai ZL; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Int J Cancer; 2005 Aug; 116(2):174-81. PubMed ID: 15800905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate malignant tumor and benign prostatic hyperplasia microenvironments in black African men: Limited infiltration of CD8+ T lymphocytes, NK-cells, and high frequency of CD73+ stromal cells.
    Mougola Bissiengou P; Montcho Comlan JG; Atsame Ebang G; Sylla Niang M; Djoba Siawaya JF
    Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1817. PubMed ID: 37092584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancer.
    Schlechte H; Lenk SV; Löning T; Schnorr D; Rudolph BD; Ditscherlein G; Loening SA
    Eur Urol; 1998; 34(5):433-40. PubMed ID: 9803007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of formalin-fixed prostate cancer tissue.
    Hood BL; Darfler MM; Guiel TG; Furusato B; Lucas DA; Ringeisen BR; Sesterhenn IA; Conrads TP; Veenstra TD; Krizman DB
    Mol Cell Proteomics; 2005 Nov; 4(11):1741-53. PubMed ID: 16091476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ-wide telomeric status in diseased and disease-free prostatic tissues.
    Heaphy CM; Fleet TM; Treat EG; Lee SJ; Smith AY; Davis MS; Griffith JK; Fischer EG; Bisoffi M
    Prostate; 2010 Sep; 70(13):1471-9. PubMed ID: 20687220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
    Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
    Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.